Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Impact of Delayed Oral Vancomycin for Severe Clostridium difficile Infection.

Shah S, Ereshefsky B, Pontiggia L, Cawley M.

Hosp Pharm. 2019 Oct;54(5):294-299. doi: 10.1177/0018578718787439. Epub 2018 Jul 23.

PMID:
31555004
2.

Intravenous Vancomycin Associated With the Development of Nephrotoxicity in Patients With Class III Obesity.

Choi YC, Saw S, Soliman D, Bingham AL, Pontiggia L, Hunter K, Chuang L, Siemianowski LA, Ereshefsky B, Hollands JM.

Ann Pharmacother. 2017 Nov;51(11):937-944. doi: 10.1177/1060028017720946. Epub 2017 Jul 14.

PMID:
28709394
3.

Variables Affecting Pharmacy Students' Patient Care Interventions during Advanced Pharmacy Practice Experiences.

Bio LL, Patterson BJ, Sen S, Bingham AL, Bowen JF, Ereshefsky B, Siemianowski LA.

Am J Pharm Educ. 2016 Sep 25;80(7):116.

4.

Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.

Ereshefsky BJ, Al-Hasan MN, Gokun Y, Martin CA.

J Chemother. 2017 Feb;29(1):30-37. doi: 10.1080/1120009X.2016.1154684. Epub 2016 Jul 4.

PMID:
27376664
5.

Fulminant Invasive Pulmonary Aspergillosis After a Near-Drowning Accident in an Immunocompetent Patient.

Ratermann KL, Ereshefsky BJ, Fleishaker EL, Thornton AC, Buch KP, Martin CA.

Ann Pharmacother. 2014 Sep;48(9):1225-1229. Epub 2014 Jun 17.

PMID:
24939635
6.

Antimicrobial management of foot infections in patients with diabetes mellitus.

Ereshefsky B, Martin C.

Orthopedics. 2010 Dec;33(12):897. doi: 10.3928/01477447-20101021-20. No abstract available.

PMID:
21117564
7.

Supplemental Content

Loading ...
Support Center